Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial

Npj mental health research Pub Date : 2024-09-03 DOI:10.1038/s44184-024-00085-8

Linda T. Betz, Gitta A. Jacob, Johannes Knitza, Michaela Koehm, Frank Behrens

{"title":"Efficacy of a cognitive-behavioral digital therapeutic on psychosocial outcomes in rheumatoid arthritis: randomized controlled trial","authors":"Linda T. Betz, Gitta A. Jacob, Johannes Knitza, Michaela Koehm, Frank Behrens","doi":"10.1038/s44184-024-00085-8","DOIUrl":null,"url":null,"abstract":"Cognitive behavioral therapy improves psychosocial outcomes in rheumatoid arthritis (RA), but access is limited. We conducted a randomized controlled trial to evaluate the efficacy of a cognitive-behavioral digital therapeutic, reclarit, on psychosocial outcomes in adult RA patients with impaired health-related quality of life. Participants were randomized to reclarit plus treatment as usual (TAU) or TAU plus educational and informational material (active control). The primary outcome was SF-36 mental (MCS) and physical (PCS) component summary scores at 3 months, with additional assessments at 6 months. reclarit significantly improved SF-36 MCS scores compared to control (mean difference 3.3 [95% CI 0.7, 5.9]; p = 0.014), with high user satisfaction and sustained improvements at 6 months. Depression, anxiety, fatigue, and social/work functioning also improved significantly, while SF-36 PCS, pain, and disability scores did not differ. In conclusion, reclarit offers immediate, effective, evidence-based and personalized psychological support for RA patients.","PeriodicalId":74321,"journal":{"name":"Npj mental health research","volume":" ","pages":"1-11"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/s44184-024-00085-8.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Npj mental health research","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s44184-024-00085-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Cognitive behavioral therapy improves psychosocial outcomes in rheumatoid arthritis (RA), but access is limited. We conducted a randomized controlled trial to evaluate the efficacy of a cognitive-behavioral digital therapeutic, reclarit, on psychosocial outcomes in adult RA patients with impaired health-related quality of life. Participants were randomized to reclarit plus treatment as usual (TAU) or TAU plus educational and informational material (active control). The primary outcome was SF-36 mental (MCS) and physical (PCS) component summary scores at 3 months, with additional assessments at 6 months. reclarit significantly improved SF-36 MCS scores compared to control (mean difference 3.3 [95% CI 0.7, 5.9]; p = 0.014), with high user satisfaction and sustained improvements at 6 months. Depression, anxiety, fatigue, and social/work functioning also improved significantly, while SF-36 PCS, pain, and disability scores did not differ. In conclusion, reclarit offers immediate, effective, evidence-based and personalized psychological support for RA patients.

Abstract Image

查看原文本刊更多论文

认知行为数字疗法对类风湿性关节炎心理社会结果的疗效：随机对照试验。

认知行为疗法可改善类风湿性关节炎（RA）患者的社会心理疗效，但其普及程度有限。我们进行了一项随机对照试验，以评估认知行为数字疗法 reclarit 对健康相关生活质量受损的成年类风湿关节炎患者的社会心理疗效。参与者被随机分配到reclarit加常规治疗（TAU）或TAU加教育和信息材料（积极对照组）。与对照组相比，reclarit 显著改善了 SF-36 MCS 评分（平均差异为 3.3 [95% CI 0.7, 5.9]；p = 0.014），用户满意度高，6 个月后仍有持续改善。抑郁、焦虑、疲劳和社交/工作功能也有明显改善，而 SF-36 PCS、疼痛和残疾评分没有差异。总之，reclarit 可为 RA 患者提供即时、有效、循证和个性化的心理支持。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Npj mental health research

自引率

0.00%

发文量